In an interview with CNBC-TV18, CFO S Ramesh spoke to Latha Venkatesh and Sonia Shenoy about a recent acquisition and other developments such as a recent FDA audit at its Indore facility as well as its plans to launch a generic version of the world‘s second-largest-selling drug Nexium in the US.
first published: Mar 17, 2015 11:22 am
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
This Tenant says Andheri West is better than SOBO | The tenant
